🔗 Permalink

Inventor profile of:

Thomas HUBER

City:

Basel

Country:

Switzerland

Published Applications:

Last publication date:

2025-11-20

Top Assignees for applications by Thomas HUBER

The entities that hold a legal rights for patent applications filed by inventor HUBER Thomas:

NOVARTIS AG 20 Basel, Switzerland
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 4 PHILADELPHIA, PA United States
Dana-Farber-Cancer Institute, Inc. 4 Boston, MA United States
Children"s Medical Center Corporation 3 Boston, MA United States
The Children's Medical Center Corporation 2 Boston, MA United States
DANA-FARBER CANCER INSITITUTE, INC. 1 Boston, MA United States
IRM LLC 1 Hamilton, Bermuda

Recent patent applications by HUBER Thomas

Thomas HUBER from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-20

US20250353916A1

Chemistry; metallurgy

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

#2 | 2025-07-03

US20250213684A1

Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#3 | 2025-05-08

US20250145703A1

Chemistry; metallurgy

ANTI-IL-17A ANTIBODIES AND THEIR USE IN TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERS

#4 | 2023-02-16

US20230052970A1

Chemistry; metallurgy

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EXPRESSING CHIMERIC ANTIGEN RECEPTOR

#5 | 2022-06-16

US20220185883A1

Chemistry; metallurgy

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

#6 | 2022-05-05

US20220133889A1

Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#7 | 2021-05-13

US20210139595A1

Chemistry; metallurgy

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

#8 | 2020-10-01

US20200308277A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#9 | 2020-09-24

US20200299379A1

Chemistry; metallurgy

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

#10 | 2020-07-16

US20200223917A1

Chemistry; metallurgy

Method of detecting TIM-3 using antibody molecules to TIM-3

#11 | 2019-06-27

US20190194315A1

Chemistry; metallurgy

ANTIBODY DRUG CONJUGATES

#12 | 2018-07-26

US20180207273A1

Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#13 | 2018-07-12

US20180194839A1

Chemistry; metallurgy

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

#14 | 2018-07-12

US20180193475A1

Human necessities

CKIT antibody drug conjugates

#15 | 2018-05-03

US20180118834A1

Chemistry; metallurgy

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor

#16 | 2018-02-15

US20180044423A1

Chemistry; metallurgy

Treatment of cancer using a CD33 chimeric antigen receptor

#17 | 2017-10-12

US20170291939A1

Chemistry; metallurgy

ANTIBODIES SPECIFIC FOR IL-17A FUSED TO HYALURONAN BINDING PEPTIDE TAGS

#18 | 2017-07-13

US20170198041A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#19 | 2017-07-13

US20170198035A1

Chemistry; metallurgy

Nucleic acid encoding anti-IL-17A antibodies

#20 | 2017-07-06

US20170190777A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#21 | 2017-02-09

US20170035905A1

Human necessities

Antibody drug conjugates

#22 | 2016-04-07

US20160096892A1

Chemistry; metallurgy

Treatment of cancer using a CD33 chimeric antigen receptor

#23 | 2016-02-11

US20160039928A1

Chemistry; metallurgy

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory

#24 | 2015-11-19

US20150329614A1

Chemistry; metallurgy

Stabilized insulin-like growth factor polypeptides

#25 | 2015-08-06

US20150218274A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#26 | 2015-06-25

US20150175692A1

Chemistry; metallurgy

Anti-IL-17A antibodies and their uses

#27 | 2014-09-18

US20140271688A1

Human necessities

Antibody drug conjugates

InventorID:

1204338 ⎘